Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Been digging into the cannabis stocks space lately and there's actually some interesting plays here if you know where to look. The whole sector had some wild swings, but the fundamentals around legalization are still pretty compelling.
Let me start with the REITs since they offer something different - steady yields while you wait for the sector to move. Innovative Industrial Properties has been a workhorse. It's basically the landlord for licensed cannabis operators, owns about 108 properties across 19 states with nearly 9 million sq ft of rentable space. They just bumped their dividend, so you're looking at solid income while holding. The other REIT play is AFC Gamma, which does lending to cannabis operators. With a 15.5% yield, it's hard to ignore. Their founder was buying shares aggressively back in the day, which usually signals confidence.
On the individual stock side, Curaleaf and Trulieve are the ones getting analyst attention. Curaleaf's got exposure to the NY market expansion and Germany operations - that's where the real growth is heading. Trulieve is basically positioned to dominate if Florida goes adult use, and the numbers suggest that's coming. Analysts have been raising price targets on both, which is usually a decent signal.
If you want easier diversification without picking individual cannabis stocks, the ETFs make sense. MJ tracks the broader cannabis space globally, while MSOS focuses on pure US plays - multi-state operators and cultivation companies. Lower fees, instant diversification, no need to research 20 different companies.
The catalysts here are still real - federal rescheduling has been in the works, Florida legalization looks increasingly likely, and you've got Europe moving faster than anyone expected. Germany's legalization alone could trigger a domino effect across the continent. That's the kind of macro shift that moves entire sectors.
My take: cannabis stocks have been beaten down enough that any weakness is probably a decent entry. The legalization narrative isn't going away, and when these catalysts actually materialize, the moves could be significant. Not financial advice, just what I'm watching in the sector right now.